Suppr超能文献

地塞米松用于患有细菌性脑膜炎的成人患者。

Dexamethasone in adults with bacterial meningitis.

作者信息

de Gans Jan, van de Beek Diederik

机构信息

Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands.

出版信息

N Engl J Med. 2002 Nov 14;347(20):1549-56. doi: 10.1056/NEJMoa021334.

Abstract

BACKGROUND

Mortality and morbidity rates are high among adults with acute bacterial meningitis, especially those with pneumococcal meningitis. In studies of bacterial meningitis in animals, adjuvant treatment with corticosteroids has beneficial effects.

METHODS

We conducted a prospective, randomized, double-blind, multicenter trial of adjuvant treatment with dexamethasone, as compared with placebo, in adults with acute bacterial meningitis. Dexamethasone (10 mg) or placebo was administered 15 to 20 minutes before or with the first dose of antibiotic and was given every 6 hours for four days. The primary outcome measure was the score on the Glasgow Outcome Scale at eight weeks (a score of 5, indicating a favorable outcome, vs. a score of 1 to 4, indicating an unfavorable outcome). A subgroup analysis according to the causative organism was performed. Analyses were performed on an intention-to-treat basis.

RESULTS

A total of 301 patients were randomly assigned to a treatment group: 157 to the dexamethasone group and 144 to the placebo group. The base-line characteristics of the two groups were similar. Treatment with dexamethasone was associated with a reduction in the risk of an unfavorable outcome (relative risk, 0.59; 95 percent confidence interval, 0.37 to 0.94; P=0.03). Treatment with dexamethasone was also associated with a reduction in mortality (relative risk of death, 0.48; 95 percent confidence interval, 0.24 to 0.96; P=0.04). Among the patients with pneumococcal meningitis, there were unfavorable outcomes in 26 percent of the dexamethasone group, as compared with 52 percent of the placebo group (relative risk, 0.50; 95 percent confidence interval, 0.30 to 0.83; P=0.006). Gastrointestinal bleeding occurred in two patients in the dexamethasone group and in five patients in the placebo group.

CONCLUSIONS

Early treatment with dexamethasone improves the outcome in adults with acute bacterial meningitis and does not increase the risk of gastrointestinal bleeding.

摘要

背景

急性细菌性脑膜炎成年患者的死亡率和发病率很高,尤其是肺炎球菌性脑膜炎患者。在动物细菌性脑膜炎研究中,皮质类固醇辅助治疗具有有益效果。

方法

我们进行了一项前瞻性、随机、双盲、多中心试验,对比地塞米松与安慰剂对急性细菌性脑膜炎成年患者的辅助治疗效果。地塞米松(10毫克)或安慰剂在首剂抗生素之前或与之同时给药,15至20分钟内给予,每6小时一次,共四天。主要结局指标是八周时的格拉斯哥预后评分(评分5表示预后良好,评分1至4表示预后不良)。根据致病微生物进行亚组分析。分析按意向性治疗原则进行。

结果

共有301例患者被随机分配至治疗组:157例至地塞米松组,144例至安慰剂组。两组的基线特征相似。地塞米松治疗可降低不良结局风险(相对风险,0.59;95%置信区间,0.37至0.94;P = 0.03)。地塞米松治疗还可降低死亡率(死亡相对风险,0.48;95%置信区间,0.24至0.96;P = 0.04)。在肺炎球菌性脑膜炎患者中,地塞米松组26%出现不良结局,而安慰剂组为52%(相对风险,0.50;95%置信区间,0.30至0.83;P = 0.006)。地塞米松组有2例患者发生胃肠道出血,安慰剂组有5例。

结论

早期使用地塞米松可改善急性细菌性脑膜炎成年患者的预后,且不会增加胃肠道出血风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验